For readers less familiar with the name, here is some background on 4DMedical Ltd (ASX: 4DX). 4DMedical is a respiratory medical-technology company whose imaging software analyses lung function from scans. It is commercialising in the United States and Australia. It sits in the large-cap …
Among emerging Australian healthcare technology companies, 4DMedical Ltd (ASX: 4DX) has built a distinctive position through its focus on respiratory imaging and functional lung analysis. The company’s proprietary technologies are designed to transform standard medical scans into advanced clinical insights, helping healthcare professionals assess …
Shares in Pro Medicus advanced after the health imaging technology company announced a $16 million contract renewal with a major Ohio State medical centre, extending one of its US relationships and reinforcing the strength of itsFranchisein the world’s largest healthcare market. The renewal was …
EBR Systems (ASX:EBR) traded at A$0.47 on 3 June 2026, with the announcement of a large-scale capital raising released shortly thereafter. TheEquityhas remained closely tied to clinical execution milestones and funding developments, reflecting its position as a medical technology company in a commercialisation phase …
Careteq Limited (ASX:CTQ) has announced that strategic investor Antanas Guoga, widely known as Tony G, has elected to convert his holding of unquoted convertible notes into ordinary shares, a move that leaves the healthcare technology company with a simplifiedCapital Structureand no convertible notes outstanding.
Control Bionics Ltd (ASX:CBL) shares climbed 18.64% to AUD 0.070 during the afternoon session on 4 June 2026 after the company released an update detailing progress across its commercial operations, customer relationships and technology deployment initiatives. The stock has also delivered a gain of …
Optiscan Imaging Ltd (ASX:OIL) has reported a significant milestone in its first in-human breast cancer imaging study, announcing that half of the targeted patient cohort has now been enrolled and imaged. The study, being conducted inPartnershipwith The Royal Melbourne Hospital (RMH), is assessing how …
Racura Oncology Ltd (ASX:RAC) shares rose 1.39% to AUD 2.54 during the morning session on 4 June 2026 after the company announced a strategicInvestmentfrom a specialist institutional investor focused on emerging healthcare companies. The stock has delivered a gain of 113.87% over the past …
Island Pharmaceuticals Ltd (ASX:ILA) shares traded 2.70% higher at AUD 0.38 during the morning session on 4 June 2026 after the company announced the commencement of a Good Manufacturing Practice (GMP) manufacturing campaign for its antiviral candidate Galidesivir.
Pro Medicus (ASX:PME) traded at AUD 162.00 on June 4, 2026, gaining AUD 2.37 or 1.48% on the day. The stock's absolute price level — at AUD 162, one of the higher absolute prices among ASX technology companies — reflects years of consistent contract …